Love it. Thanks, Jake. I've written here befor
Post# of 148112
I've written here before that, if you could prove that Amarex simply following through would have produced an approval, the rest is pretty easy. We all know about the toxic loans that CYDY has had to take, month after month; the fact that CYDY didn't manage to get on NASDAQ in the spring of 2020 was due, too, to the RTF. Approval would have led to revenues too, of course.
But I would guess that a case like this would take a long long time, wouldn't it? One would assume NSF is not going to settle for, say, a billion bucks.